madison.com — On March 29, an FDA advisory panel consisting of outside experts (that the FDA itself does not have) reviewed Provenge for the FDA and overwhelmingly recommended approval of Provenge.But then the FDA did not approve it due to "internal conflicts of personal nature"
Dec 18, 2007 View in Crawl 4
